Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndromeDickson-Humphries, Tania MPAS, PA-C; Bottenberg, B. DO, FACOI, FNLA; Kuntz, Susan PhDJournal of the American Academy of Physician Assistants: July 2013 - Volume 26 - Issue 7 - p 13–18 doi: 10.1097/01.JAA.0000431506.00627.be Cardiovascular Medicine Abstract Author Information Abstract ABSTRACT: Cardiovascular disease remains the leading cause of death in men and women in the United States. Aggressive treatment of insulin resistance and its associated lipid abnormalities remains a top priority for preventing cardiovascular morbidity and mortality. Author Information Tania Dickson-Humphries is a PA in vascular surgery for Carson Surgical Group in Carson City, Nevada, and a recent graduate of the University of North Dakota PA program. B. Bottenberg practices internal medicine and lipidology in Carson City, Nevada, and is president-elect of the Pacific Lipid Association. Susan Kuntz is an assistant professor in the department of family and community medicine in the PA program at the University of North Dakota at Grand Forks. The authors have indicated no relationships to disclose relating to the content of this article. Earn Category I CME credit by reading this article and the article beginning on page 20 and successfully completing the posttest on page 28. Successful completion is defined as a cumulative score of at least 70% correct. This material has been reviewed and is approved for 1 hour of clinical Category I (Preapproved) CME credit by the AAPA. The term of approval is for 1 year from the publication date of July 2013. © 2013 American Academy of Physician Assistants.